BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16314734)

  • 1. Differential expression of angioregulatory matricellular proteins in posterior uveal melanoma.
    Ordonez JL; Paraoan L; Hiscott P; Gray D; García-Fiñana M; Grierson I; Damato B
    Melanoma Res; 2005 Dec; 15(6):495-502. PubMed ID: 16314734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth.
    Boyd SR; Tan DS; de Souza L; Neale MH; Myatt NE; Alexander RA; Robb M; Hungerford JL; Cree IA
    Br J Ophthalmol; 2002 Apr; 86(4):440-7. PubMed ID: 11914215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
    Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
    Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma.
    Mäkitie T; Summanen P; Tarkkanen A; Kivelä T
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2471-80. PubMed ID: 10509639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential zonal expression and adrenocorticotropin regulation of secreted protein acidic and rich in cysteine (SPARC), a matricellular protein, in the midgestation human fetal adrenal gland: implications for adrenal development.
    Ishimoto H; Ginzinger DG; Matsumoto T; Hattori Y; Furuya M; Minegishi K; Tanaka M; Yoshimura Y; Jaffe RB
    J Clin Endocrinol Metab; 2006 Aug; 91(8):3208-14. PubMed ID: 16735494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma.
    Shah AA; Bourne TD; Murali R
    Pathology; 2013 Dec; 45(7):651-6. PubMed ID: 24247622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma.
    Ledda F; Bravo AI; Adris S; Bover L; Mordoh J; Podhajcer OL
    J Invest Dermatol; 1997 Feb; 108(2):210-4. PubMed ID: 9008236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of matricellular proteins thrombospondin-1 and osteonectin during RPE cell migration in proliferative vitreoretinopathy.
    Sheridan CM; Magee RM; Hiscott PS; Hagan S; Wong DH; McGalliard JN; Grierson I
    Curr Eye Res; 2002 Nov; 25(5):279-85. PubMed ID: 12658547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of caveolin-1 and phosphoinositol-3 kinase expression in primary uveal melanomas.
    Stenzel M; Tura A; Nassar K; Rohrbach JM; Grisanti S; Lüke M; Lüke J
    Clin Exp Ophthalmol; 2016 Jul; 44(5):400-9. PubMed ID: 26590370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MuSIC report III: tumour microcirculation patterns and development of metastasis in long-term follow-up of melanocytic uveal tumours.
    Klingenstein A; Schaumberger MM; Freeman WR; Folberg R; Mueller AJ; Schaller UC
    Acta Ophthalmol; 2016 Mar; 94(2):175-81. PubMed ID: 26426375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mouse model for primary uveal melanoma: a pilot study.
    Süsskind D; Hurst J; Rohrbach JM; Schnichels S
    Clin Exp Ophthalmol; 2017 Mar; 45(2):192-200. PubMed ID: 27505446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma.
    Lau CP; Poon RT; Cheung ST; Yu WC; Fan ST
    J Pathol; 2006 Dec; 210(4):459-68. PubMed ID: 17029219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: is there prognostic relevance of proliferating endothelium?
    Ziemssen F; Wegner R; Wegner J; Tatar O; Süsskind D; Gelisken F; Rohrbach M; Bartz-Schmidt KU; Grisanti S
    Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1124-31. PubMed ID: 16523306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPARC is expressed in human uveal melanoma and its abrogation reduces tumor cell proliferation.
    Maloney SC; Marshall JC; Antecka E; Orellana ME; Fernandes BF; Martins C; Castiglione E; DI Cesare S; Logan P; Burnier MN
    Anticancer Res; 2009 Aug; 29(8):3059-64. PubMed ID: 19661316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secreted protein, acidic and rich in cysteine (SPARC) expression in astrocytic tumour cells negatively correlates with proliferation, while vascular SPARC expression is associated with patient survival.
    Capper D; Mittelbronn M; Goeppert B; Meyermann R; Schittenhelm J
    Neuropathol Appl Neurobiol; 2010 Apr; 36(3):183-97. PubMed ID: 20132490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microphthalmia transcription factor analysis in posterior uveal melanomas.
    Mouriaux F; Vincent S; Kherrouche Z; Maurage CA; Planque N; Monté D; Labalette P; Saule S
    Exp Eye Res; 2003 Jun; 76(6):653-61. PubMed ID: 12742347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of VLA-2, VLA-3, and alpha(v) integrin receptors in uveal melanoma: association with microvascular architecture of the tumour and prognostic value.
    Anastassiou G; Schilling H; Djakovic S; Bornfeld N
    Br J Ophthalmol; 2000 Aug; 84(8):899-902. PubMed ID: 10906100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombospondin 1, thrombospondin 2 and the eye.
    Hiscott P; Paraoan L; Choudhary A; Ordonez JL; Al-Khaier A; Armstrong DJ
    Prog Retin Eye Res; 2006 Jan; 25(1):1-18. PubMed ID: 15996506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma.
    Coupland SE; Anastassiou G; Stang A; Schilling H; Anagnostopoulos I; Bornfeld N; Stein H
    J Pathol; 2000 Jun; 191(2):120-6. PubMed ID: 10861569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteonectin expression correlates with clinical outcome in thin cutaneous malignant melanomas.
    Massi D; Franchi A; Borgognoni L; Reali UM; Santucci M
    Hum Pathol; 1999 Mar; 30(3):339-44. PubMed ID: 10088554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.